Barnes-Jewish Hospital is the largest hospital in the U.S. state of Missouri. Located in the Central West End neighborhood of St. Louis, it is the adult teaching hospital for the Washington University School of Medicine and a major component of the Washington University Medical Center.

There are 1,266 beds in Barnes-Jewish Hospital.

During the past decade, Barnes-Jewish Hospital conducted 156 clinical trials. In the 10-year time frame, 156 clinical trials started and 157 clinical trials were completed, i.e. on average, 100.6% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 58 clinical trials were completed. i.e. 118.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barnes-Jewish Hospital" #1 sponsor was "Washington University School of Medicine" with 93 trials, followed by "Alliance for Clinical Trials in Oncology" with 54 trials sponsored, "Pfizer" with 45 trials sponsored, "Abbott Medical Devices" with 21 trials sponsored and "Medical College of Wisconsin" with 21 trials sponsored. Other sponsors include 198 different institutions and companies that sponsored additional 112 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barnes-Jewish Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 23 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 22 trials as a collaborator, "National Marrow Donor Program" with 17 trials as a collaborator and "Cancer and Leukemia Group B" with 16 trials as a collaborator. Other collaborators include 206 different institutions and companies that were collaborators in the rest 128 trials.

According to Clinical.Site data, the most researched conditions in "Barnes-Jewish Hospital" are "Lung Cancer" (18 trials), "Lymphoma" (16 trials), "Leukemia" (13 trials), "Coronary Artery Disease" (12 trials) and "Breast Cancer" (9 trials). Many other conditions were trialed in "Barnes-Jewish Hospital" in a lesser frequency.

Most popular intervention types in "Barnes-Jewish Hospital" are "Drug" (214 trials), "Device" (110 trials), "Other" (74 trials), "Procedure" (46 trials) and "Biological" (43 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "cyclophosphamide" (11 trials), "doxorubicin hydrochloride" (10 trials), "etoposide" (9 trials) and "paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Barnes-Jewish Hospital" are 377 trials for "All" genders, 45 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 102 active trials in "Barnes-Jewish Hospital". 3 are not yet recruiting, 48 are recruiting, 48 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 266 completed trials in Barnes-Jewish Hospital, undefined suspended trials, and 44 terminated clinical trials to date.

Out of the total trials that were conducted in Barnes-Jewish Hospital, 25 "Phase 1" clinical trials were conducted, 119 "Phase 2" clinical trials and 95 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 137 trials that are defined as “Not Applicable".

Barnes-Jewish Hospital has several departments that took part in Clinical trials: "Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis" - 190 trials, "Barnes-Jewish Hospital Emergency Department" - 3 trials, "Barnes-Jewish Hospital Department of Pharmacy" - 2 trials, "Barnes-Jewish Hospital - Gastroenterology" - 2 trials, "Barnes-Jewish Dialysis Center" - 2 trials, "Washington University and Barnes Jewish Heart & Vascular Center" - 2 trials